Hochschulschrift
Targeting CD44v6, a co-receptor for Met and VEGFR-2 in endothelial cells, inhibits tumour angiogenesis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Heidelberg, Univ., Diss., 2009
- Keyword
-
Angiogenese ; Endothel
Krebs
Onkologie
- Creator
- URN
-
urn:nbn:de:bsz:16-opus-98141
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Subconjunctival aflibercept inhibits corneal angiogenesis and VEGFR-3+CD11b+ cells
Acute, but not constitutive, loss of endothelial β3-integrin inhibits tumour growth and angiogenesis
Indirubin derivative E804 inhibits angiogenesis
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Lycorine inhibits angiogenesis by docking to PDGFRα
P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells
The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis
Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
COCO/DAND5 inhibits developmental and pathological ocular angiogenesis
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Subconjunctival aflibercept inhibits corneal angiogenesis and VEGFR-3+CD11b+ cells
Acute, but not constitutive, loss of endothelial β3-integrin inhibits tumour growth and angiogenesis
Indirubin derivative E804 inhibits angiogenesis
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Lycorine inhibits angiogenesis by docking to PDGFRα
P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells
The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis
Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
COCO/DAND5 inhibits developmental and pathological ocular angiogenesis
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Subconjunctival aflibercept inhibits corneal angiogenesis and VEGFR-3+CD11b+ cells
Acute, but not constitutive, loss of endothelial β3-integrin inhibits tumour growth and angiogenesis
Indirubin derivative E804 inhibits angiogenesis
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
Lycorine inhibits angiogenesis by docking to PDGFRα
P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells
The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis
Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
COCO/DAND5 inhibits developmental and pathological ocular angiogenesis